基础治疗、艾灸胰俞穴联合通络涤痰汤治疗2型糖尿病周围神经病变患者的效果

doi:10.3760/cma.j.issn.1007-1245.2024.21.026

摘要/Abstract

摘要：

目的　观察基础治疗、艾灸胰俞穴联合通络涤痰汤治疗2型糖尿病周围神经病变患者的效果。方法　选取2022年3月至2024年2月商洛市中心医院收治的痰瘀阻络型2型糖尿病周围神经病变患者93例为研究对象。根据治疗方法将其分成对照组46例与观察组47例。对照组男26例，女20例，年龄（48.53±6.27）岁。观察组男24例，女23例，年龄（49.71±7.34）岁。两组均采用基础治疗。对照组艾灸胰俞穴治疗，观察组在对照组的基础上采用通络涤痰汤治疗。对比两组中医症候评分、神经传导速度、临床疗效、血糖水平、血管内皮功能、氧化应激反应及不良反应。采用t检验、χ²检验。结果　治疗后，观察组总评分、次症评分、主症评分均低于对照组［（6.28±1.23）分比（10.12±1.97）分、（2.17±0.34）分比（4.09±0.88）分、（4.11±0.85）分（6.03±1.72）分］，差异均有统计学意义（均P<0.05）。治疗后，观察组正中神经及腓总神经的运动传导速度（motor conduction velocity，MNCV）与感觉传导速度（sensory conduction velocity，SNCV）均高于对照组［（47.25±5.76）m/s比（43.56±4.54）m/s、（49.31±5.69）m/s比（45.82±4.87）m/s、（44.17±5.88）m/s比（39.25±4.36）m/s、（46.51±5.72）m/s比（42.69±4.83）m/s］，差异均有统计学意义（均P<0.05）。观察组总有效率高于对照组［93.62%（44/47）比78.26%（36/46），P<0.05］。治疗后，观察组糖化血红蛋白（HbAlc）、餐后2 h血糖（2 h postprandial blood glucose，2hPG）、空腹血糖（fasting blood glucose，FBG）、血清内皮素-1（endothelin-1，ET-1）、血管内皮生长因子（vascular endothelial growth factor，VEGF）、丙二醛（malondialdehyde，MDA）水平均低于对照组［（6.03±1.25）%比（7.28±1.72）%、（7.21±1.24）mmol/L比（8.72±1.69）mmol/L、（5.35±0.83）mmol/L比（6.72±1.20）mmol/L、（78.32±9.08）ng/L比（115.20±12.47）ng/L、（79.85±9.30）ng/L比（112.34±13.68）ng/L、（3.65±0.68）mmol/L比（4.87±1.02）mmol/L］，血清一氧化氮（nitric oxide，NO）、超氧化物歧化酶（superoxide dismutase，SOD）水平均高于对照组［（65.41±7.38）μmol/L比（49.86±5.94）μmol/L、（165.76±18.40）U/L比（108.27±11.34）U/L］，差异均有统计学意义（P<0.05）。治疗期间，两组均未出现明显不良反应。结论　基础治疗、艾灸胰俞穴联合通络涤痰汤治疗痰瘀阻络型2型糖尿病周围神经病变患者效果确切，可提高神经传导速度，减轻氧化应激反应，改善血管内皮功能，调节血糖水平，且安全可靠。

关键词:

2型糖尿病, 艾灸, 胰俞穴, 通络涤痰汤, 痰瘀阻络型, 糖尿病周围神经病变, 临床疗效

Abstract:

Objective　To observe the effect of basic treatment, moxibustion on the Yiyu point, and Tongluo Diitan Decoction for patients with type 2 diabetic peripheral neuropathy. Methods　Ninety-three patients with type 2 diabetic peripheral neuropathy of the phlegm-stasis obstruction type treated at Shangluo Central Hospital from March 2022 to February 2024 were selected as the research objects, and were divided into a control group (46 cases) and an observation group (47 cases) according to the treatment methods. In the control group, there were 26 males and 20 females who were (48.53±6.27) years old. In the observation group, there were 24 males and 23 females who were (49.71±7.34) years old. Both groups received basic treatment. The control group received moxibustion on their Yiyu points, and the observation group took Tongluo Ditan Decoction on the basis of the control group. The scores of traditional Chinese medicine syndromes, nerve conduction velocities, clinical efficacies, blood glucose levels, vascular endothelial function, oxidative stress reaction, and adverse reactions were compared between the two groups. t test and χ² test were used. Results　After the treatment, the total score, score of secondary symptoms, and score of main symptoms of the observation group were lower than those of the control group [(6.28±1.23) vs. (10.12±1.97), (2.17±0.34) vs. (4.09±0.88), and (4.11±0.85) vs. (6.03±1.72)], with statistical differences (all P<0.05). After the treatment, the motor conduction velocity (MNCV) and sensory conduction velocity (SNCV) of the median nerve and common peroneal nerve in the observation group were higher than those in the control group [(47.25±5.76) m/s vs. (43.56±4.54) m/s, (49.31±5.69) m/s vs. (45.82±4.87) m/s, (44.17±5.88) m/s vs. (39.25±4.36) m/s, and (46.51±5.72) m/s vs. (42.69±4.83) m/s], with statistical differences (all P<0.05). The total effective rate of the observation group was higher than that of the control group [93.62% (44/47) vs. 78.26% (36/46); P<0.05]. After the treatment, the levels of glycosylated hemoglobin (HbAlc), 2 h postprandial blood glucose (2hPG), fasting blood glucose (FBG), serum endothelin-1 (ET-1), vascular endothelial growth factor (VEGF), and malondialdehyde (MDA) in the observation group were lower than those in the control group [(6.03±1.25)% vs. (7.28±1.72)%, (7.21±1.24) mmol/L vs. (8.72±1.69) mmol/L, (5.35±0.83) mmol/L vs. (6.72±1.20) mmol/L, (78.32±9.08) ng/L vs. (115.20±12.47) ng/L, (79.85±9.30) ng/L vs. (112.34 ±13.68) ng/L, and (3.65±0.68) mmol/L vs. (4.87±1.02) mmol/L]; the levels of serum nitric oxide (NO) and superoxide dismutase (SOD) in the observation group were higher than those in the control group [(65.41±7.38) μmol/L vs. (49.86±5.94) μmol/L and (165.76±18.40) U/L vs. (108.27±11.34) U/L]; there were statistical differences (all P<0.05). During the treatment, there were no obvious adverse reactions in both groups. Conclusion　Basic treatment, moxibustion on the Yiyu point, and Tongluo Ditan Decoction for patients with type 2 diabetic peripheral neuropathy is effective, can increase nerve conduction speed, reduce oxidative stress reaction, improve vascular endothelial function, and regulate blood sugar level, and is safe and reliable.

Key words:

Type 2 diabetes, Moxibustion, Yiyu point, Tongluo Ditan Decoction, Phlegm-stasis obstruction type, Diabetic peripheral neuropathy, , Clinical effect

张彦芬郭浩楠吴红群冀花王涛.

基础治疗、艾灸胰俞穴联合通络涤痰汤治疗2型糖尿病周围神经病变患者的效果 [J]. 国际医药卫生导报, 2024, 30(21): 3656-3661.

Zhang Yanfen, Guo Haonan, Wu Hongqun, Ji Hua, Wang Tao.

Effect of basic treatment, moxibustion on Yiyu point, and Tongluo Ditan Decoction for patients with type 2 diabetic peripheral neuropathy [J]. International Medicine and Health Guidance News, 2024, 30(21): 3656-3661.

参考文献

[1] Elafros MA, Andersen H, Bennett DL, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments [J]. Lancet Neurol, 2022, 21(10): 922-936. DOI: 10.1016/S1474-4422(22)00188-0.
[2] Jang HN, Oh TJ. Pharmacological and nonpharmacological treatments for painful diabetic peripheral neuropathy [J]. Diabetes Metab J, 2023, 47(6): 743-756. DOI: 10.4093/dmj.2023.0018.
[3] 刘月莹. 祛痰化瘀宣痹组方治疗糖尿病周围神经病变(痰瘀阻络型)的临床疗效观察[D]. 张家口:河北北方学院,2023.
[4] 谈力欣,崔杰,张秀云,等. 艾灸胰俞穴对2型糖尿病周围神经病变患者血糖波动及感觉神经传导速度的影响[J]. 河北中医,2023,45(11):1876-1879. DOI:10.3969/j.issn. 1002-2619.2023.11.026.
[5] 邓海南,白德龙,崔景军,等. 通络涤痰汤治疗痰瘀阻络型缺血性脑卒中的疗效及对血清IL-8、ET-1、NO水平和血液流变学的影响[J]. 现代中西医结合杂志,2023,32(15):2128-2131. DOI:10.3969/j.issn.1008-8849.2023.15.015.
[6] «中国老年型糖尿病防治临床指南»编写组. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中国糖尿病杂志,2022,30(1):2-51. DOI:10.3969/j.issn.1006-6187.2 022.01.002.
[7] 谢云,冯凭,BOULTON AJ,等. 美国糖尿病协会关于糖尿病神经病变的诊断和治疗指南[J]. 国际内分泌代谢杂志,2009,29(6):427-432. DOI:10.3760/cma.j.issn.1673-4157. 2009.06.020.
[8] 中华中医药学会糖尿病分会. 糖尿病周围神经病变中医临床诊疗指南(2016年版)[J]. 中医杂志,2017,58(7):625-630. DOI:10.13288/j.11-2166/r.2017.07.025.
[9] 中华人民共和国卫生部.中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002:60-67.
[10] Putz Z, Tordai D, Hajdú N, et al. Vitamin D in the prevention and treatment of diabetic neuropathy [J]. Clin Ther, 2022, 44(5): 813-823. DOI: 10.1016/j.clinthera. 2022.03.012.
[11] Nabrdalik K, Kwiendacz H, Moos J, et al. Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease: the silesia diabetes-heart project [J]. Curr Probl Cardiol, 2023, 48(8): 101726. DOI: 10.1016/j.cpcardiol.2023.101726.
[12] Galiero R, Caturano A, Vetrano E, et al. Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options [J]. Int J Mol Sci, 2023, 24(4): 3554. DOI: 10.3390/ijms24043554.
[13] Bragg S, Marrison ST, Haley S. Diabetic peripheral neuropathy: prevention and treatment [J]. Am Fam Physician, 2024, 109(3): 226-232.
[14] Rafiullah M, Siddiqui K. Pharmacological treatment of diabetic peripheral neuropathy: an update [J]. CNS Neurol Disord Drug Targets, 2022, 21(10): 884-900. DOI: 10.2174/1871527320666210303111939.
[15] 廖冰. 温和灸治疗脾肾阳虚型糖尿病周围神经病变的临床疗效观察[D]. 广州:广州中医药大学,2021.
[16] 李美玲. 岭南火针治疗痰瘀阻络型糖尿病多发性周围神经病变的临床研究[D]. 广州:广州中医药大学,2023.
[17] 唐强. 少阳经针刺论治痰瘀阻络型2型糖尿病周围神经病变的临床疗效分析[D]. 承德:承德医学院,2022.
[18] 孔鑫靓,刘雁峰. 基于网络药理学和分子对接探讨丹参-郁金治疗多囊卵巢综合征的作用机制[J]. 世界中医药,2022,17(15):2155-2161. DOI:10.3969/j.issn.1673-7202. 2022.15.011.
[19] 柴一琳,王国强,战群,等. 益气活血类方治疗糖尿病周围神经病变作用机制研究进展[J]. 长春中医药大学学报,2023,39(7):822-826. DOI:10.13463/j.cnki.cczyy.2023.07.025.
[20] 王开欣,张攀,罗涛,等. 芍药甘草汤加味联合中药熏洗治疗阴虚血瘀型糖尿病周围神经病变临床研究[J]. 辽宁中医药大学学报,2023,25(9):212-216. DOI:10.13194/j.issn. 1673-842x.2023.09.042.
[21] 王金海,蒋凯,韩培,等. 依帕司他联合羟苯磺酸钙治疗糖尿病周围神经病变的效果及其对氧化应激反应的影响[J]. 中华内分泌外科杂志,2023,17(3):332-336. DOI:10.3760/cma.j.cn.115807-20221107-00310.
[22] 姜丽燕,潘红博,陈坤,等. 血清铁蛋白、维生素D在糖尿病周围神经病变中的血清水平及与氧化应激反应的关系[J]. 实用临床医药杂志,2023,27(5):110-113,118. DOI:10.7619/jcmp.20222301.
[23] 铁岩,李潇,杨鑫伟,等. 鸡血藤治疗糖尿病周围神经病变的网络药理学研究及机制探讨[J]. 环球中医药,2023,16(9):1775-1784. DOI:10.3969/j.issn.1674-1749.2023.09.009.
[24] 蔡世揿,毛雷鸣,周丽芳,等. 基于网络药理学、分子对接和动物实验探究党参-茯苓药对对酒精性肝病的作用机制[J]. 中国药理学通报,2024,40(5):945-954. DOI:10.12360/CPB202308007.
[25] 张道培,刘梦琳,张怀亮. 基于网络药理学探讨加味通窍活血汤治疗瘀血阻窍型后循环缺血的作用机制[J]. 中医学报,2023,38(10):2138-2147. DOI:10.16368/j.issn.1674- 8999. 2023.10.345.
[26] 杨娜,田皎丁,孟晶晶,等. 针刺联合黄芪桂枝五物汤对2型糖尿病周围神经病变的临床疗效及对患者微血管内皮细胞功能的影响[J]. 四川中医,2024,42(3):140-144.